Moneycontrol PRO
you are here: HomeNewsBusiness

Laurus Labs: Diversification away from ARVs on track

The share of the Laurus antiretroviral business in total is expected to be less than 1/3rd by 2025, compared to 50 percent now as the company’s other engines of growth gain traction

January 31, 2022 / 11:37 AM IST
Laurus Labs: Diversification away from ARVs on track

Laurus Labs

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Laurus Labs (CMP: Rs 500; Market Cap: Rs 26,857 crore) has posted a weak set of numbers in the recent quarterly results, dragged by channel de-stocking in the ARV (antiretroviral) business. Since the ARV business still constitutes the bulk of sales, the obvious investor concern will be whether the company would be able to meet the target of $1 billion revenue in FY23. Further, COVID opportunity has moderated. The Molnupiravir (Innovator: Merck) opportunity is also not seen as a material one...

  • PRO Panorama

    Moneycontrol Pro Panorama | GST: A simple, reliable tax still a distant dream?

    May 20, 2022 / 04:41 PM IST

    In today’s edition of Moneycontrol Pro Panorama: A peek into Strategy Lab, ITC makes it to Weekly Tactical, wide canvas for Nazara, shock proof your portfolio and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Losing faith

    May 7, 2022 / 10:05 AM IST

    Central banks have a trust problem with financial markets over their ability to steer economies towards a soft landing

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers